{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:34:41Z","timestamp":1791221681676,"version":"4.1.0"},"reference-count":30,"publisher":"BMJ","issue":"6313","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ"],"published-print":{"date-parts":[[1982,2,6]]},"DOI":"10.1136\/bmj.284.6313.375","type":"journal-article","created":{"date-parts":[[2009,4,2]],"date-time":"2009-04-02T15:00:59Z","timestamp":1238684459000},"page":"375-379","source":"Crossref","is-referenced-by-count":146,"title":["Low-molecular-weight heparin and prevention of postoperative deep vein thrombosis."],"prefix":"10.1136","volume":"284","author":[{"given":"V V","family":"Kakkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Djazaeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Fok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M F","family":"Scully","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Westwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1600-0609.1968.tb00865.x","article-title":"Inhibition of the thrombin-fibrinogen reaction by heparin and purified cofactor","volume":"5","author":"Abildgaard, U.","year":"1968","unstructured":"Abildgaard U. Inhibition of the thrombin-fibrinogen reaction by heparin and purified cofactor. Scand J Haematol 1968;5:440-5.","journal-title":"Scand J Haematol"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/246355a0","article-title":"Anticoagulant action of heparin","volume":"246","author":"Damus, P.S.; Hick, S.; Rosenberg, R.W.","year":"1973","unstructured":"Damus PS, Hick S, Rosenberg RW. Anticoagulant action of heparin. Nature 1973;246:355.","journal-title":"Nature"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1055\/s-0038-1647922","article-title":"The effect of antithrombin III on the activity of the coagulation factor VII, IX and X","volume":"35","author":"Osterud, B.; Miller-Andersson, M.; Abildgaard, U.; Prydz, H.","year":"1976","unstructured":"Osterud B, Miller-Andersson M, Abildgaard U, Prydz H. The effect of antithrombin III on the activity of the coagulation factor VII, IX and X. Thromb Haemostas 1976;35:295-301.","journal-title":"Thromb Haemostas"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1042\/bj1750691","article-title":"The molecular weight dependance of the anticoagulant activity of heparin","volume":"175","author":"Laurent, T.C.; Tengblad, A.; Thunberg, L.; Hook, M.; Lindahal, U.","year":"1978","unstructured":"Laurent TC, Tengblad A, Thunberg L, Hook M, Lindahal U. The molecular weight dependance of the anticoagulant activity of heparin. BiochemJ7 1978;175:691-701.","journal-title":"BiochemJ7"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/0049-3848(79)90159-2","article-title":"Molecular weight dependency of the heparin potentiated inhibition of thrombin and activated factor X. Effect of heparin neutralisation in plasma","volume":"15","author":"Andersson, L.O.; Barrowcliffe, T.W.; Holmer, E.; Johnson, E.A.; Soderstrom, G.","year":"1979","unstructured":"Andersson LO, Barrowcliffe TW, Holmer E, Johnson EA, Soderstrom G. Molecular weight dependency of the heparin potentiated inhibition of thrombin and activated factor X. Effect of heparin neutralisation in plasma. Thromb Res 1979;15:531-41.","journal-title":"Thromb Res"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0008-6215(00)87070-6","article-title":"The relationship of molecular weight, and sulfate content and distribution to anticoagulant activity of heparin preparations","volume":"37","author":"Cifonelli, J.A.","year":"1974","unstructured":"Cifonelli JA. The relationship of molecular weight, and sulfate content and distribution to anticoagulant activity of heparin preparations. Carbohydr Res 1974;37:145-54.","journal-title":"Carbohydr Res"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0008-6215(00)84041-0","article-title":"The molecular weight range of mucosal heparin preparations","volume":"51","author":"Johnson, E.A.; Malloy, B.","year":"1976","unstructured":"Johnson EA, Malloy B. The molecular weight range of mucosal heparin preparations. Carbohydr Res 1976;51:119-23.","journal-title":"Carbohydr Res"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0049-3848(76)90105-5","article-title":"Anticoagulant properties of heparin fractionated by affinity chromatography on matrix bound antithrombin III and by gel filtration","volume":"9","author":"Andersson, L.O.; Barrowcliffe, T.W.; Holmer, E.; Johnson, E.A.; Sims, G.E.C.","year":"1976","unstructured":"Andersson LO, Barrowcliffe TW, Holmer E, Johnson EA, Sims GEC. Anticoagulant properties of heparin fractionated by affinity chromatography on matrix bound antithrombin III and by gel filtration. Thromb Res 1976;9:575-83.","journal-title":"Thromb Res"},{"key":"ref_9","first-page":"586","article-title":"The separation of active and inactive form of heparin. Biochem Biophys Res Commun 1976; 69: 570-6. '0 Johnson EA, Kirkwood TBL, Stirling Y, et al. Four heparin preparations. Anti-Xa potentiating effect of heparin after subcutaneous injection","volume":"35","author":"Lam, L.H.; Silbert, J.E.; Rosenberg, R.D.","year":"1976","unstructured":"Lam LH, Silbert JE, Rosenberg RD. The separation of active and inactive form of heparin. Biochem Biophys Res Commun 1976;69:570-6. '0 Johnson EA, Kirkwood TBL, Stirling Y, et al. Four heparin preparations. Anti-Xa potentiating effect of heparin after subcutaneous injection. Thromb Haemostas 1976;35:586-91.","journal-title":"Thromb Haemostas"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0049-3848(78)90297-9","article-title":"Anticoagulant activities of four unfractionated and fractionated heparins","volume":"12","author":"Lane, D.A.; MacGregor, I.R.; Michalski, R.; Kakkar, VV","year":"1978","unstructured":"Lane DA, MacGregor IR, Michalski R, Kakkar VV. Anticoagulant activities of four unfractionated and fractionated heparins. Thromb Res 1978;12:257-71.","journal-title":"Thromb Res"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0049-3848(78)90082-8","article-title":"Anticoagulant activities of lung and mucous heparins","volume":"12","author":"Barrowcliffe, T.W.; Johnson, E.A.; Eggleton, C.H.; Thomas, D.P.","year":"1978","unstructured":"Barrowcliffe TW, Johnson EA, Eggleton CH, Thomas DP. Anticoagulant activities of lung and mucous heparins. Thromb Res 1978;12:27-36.","journal-title":"Thromb Res"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1365-2141.1979.tb05894.x","article-title":"Anticoagulant activities of high and low molecular weight heparin fractions","volume":"41","author":"Barrowcliffe, T.W.; Johnson, E.A.; Eggleton, C.A.; Kemball-Cook, G.; Thomas, D.P.","year":"1979","unstructured":"Barrowcliffe TW, Johnson EA, Eggleton CA, Kemball-Cook G, Thomas DP. Anticoagulant activities of high and low molecular weight heparin fractions. Br J Haematol 1979;41:573-83.","journal-title":"Br J Haematol"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0049-3848(80)90356-4","article-title":"Anti-Xa active heparin oligosaccharides","volume":"18","author":"Choay, J.; Lormeau, J.C.; Petitou, M.","year":"1980","unstructured":"Choay J, Lormeau JC, Petitou M, et al. Anti-Xa active heparin oligosaccharides. Thromb Res 1980;18:573-8.","journal-title":"Thromb Res"},{"key":"ref_14","first-page":"133","volume":"1968","author":"Caen, J.; Larrieu, M.J.; L'hemostase, Samama M.","unstructured":"Caen J, Larrieu MJ, Samama M. L'hemostase. Paris: Expansion Scientifieque Francaise, 1968:133-5.","journal-title":"Paris: Expansion Scientifieque Francaise"},{"key":"ref_15","first-page":"298","article-title":"Plasma heparin: a unique practical, submicrogram-sensitive assay","volume":"81","author":"Yin, E.T.; Wessler, S.; Butler, J.V.","year":"1973","unstructured":"Yin ET, Wessler S, Butler JV. Plasma heparin: a unique practical, submicrogram-sensitive assay. J Lab Clin Med 1973;81:298-310.","journal-title":"J Lab Clin Med"},{"key":"ref_16","first-page":"540","article-title":"125I-fibrinogen test adapted for routine screening","volume":"i:","year":"1970","unstructured":"Kakkar VV, Nicolaides AN, Renney JTG, Friend JR, Clarke MD. 125I-fibrinogen test adapted for routine screening. Lancet 1970;i:540-2.","journal-title":"Lancet"},{"issue":"45","key":"ref_17","first-page":"257","article-title":"The problems of thrombosis in the deep veins of the legs","volume":"1969","author":"Kakkar, VV","unstructured":"Kakkar VV. The problems of thrombosis in the deep veins of the legs. Ann R Coll Surg Engi 1969;45:257-76.","journal-title":"Ann R Coll Surg Engi"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0009-8981(77)90181-4","article-title":"Methods for semimicro or automated determination of thrombin, antithrombin, and heparin co-factor, using the substrate H-D-Phe-Pip-Arg-p-Nitroanilide 2-HC1","volume":"79","author":"Scully, M.F.; Kakkar, VV","year":"1977","unstructured":"Scully MF, Kakkar VV. Methods for semimicro or automated determination of thrombin, antithrombin, and heparin co-factor, using the substrate H-D-Phe-Pip-Arg-p-Nitroanilide 2-HC1. Clin Chim Acta 1977;79:595-602.","journal-title":"Clin Chim Acta"},{"key":"ref_19","article-title":"Bleeding disorders","author":"Hardisty, R.M.; Ingram, G.I.C.","year":"1965","unstructured":"Hardisty RM, Ingram GIC. Bleeding disorders. Oxford: 1965."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S0022-2275(20)41752-3","article-title":"A stable radioactive substrate emulsion for assay of lipoprotein lipase","volume":"17","author":"Nilsson-Ehle, P.; Schotz, N.C.","year":"1976","unstructured":"Nilsson-Ehle P, Schotz NC. A stable radioactive substrate emulsion for assay of lipoprotein lipase. J Lipid Res 1976;17:536-41.","journal-title":"J Lipid Res"},{"key":"ref_21","first-page":"83","article-title":"Determination of prekallikrein in human plasma. Optimal conditions of activating prekallikrein","volume":"91","author":"Kluft, C.","year":"1978","unstructured":"Kluft C. Determination of prekallikrein in human plasma. Optimal conditions of activating prekallikrein. J Lab Clin Med 1978;91:83-95.","journal-title":"J Lab Clin Med"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/0049-3848(80)90031-6","article-title":"Rapid radioimmunoassay of human fibrinopeptide A. Removal of cross reacting fibrinogen with Bentonite","volume":"19","author":"Kockum, C.; Frebeluis, S.","year":"1980","unstructured":"Kockum C, Frebeluis S. Rapid radioimmunoassay of human fibrinopeptide A. Removal of cross reacting fibrinogen with Bentonite. Thromb Res 1980;19:589-96.","journal-title":"Thromb Res"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0161-4630(79)90059-4","article-title":"Detection of thromboxane B2 in variant angina","volume":"2","author":"Levy, R.C.; Smith, J.B.; Silver, M.T.; Saia, J.; Walnski, P.; Weiner, L.","year":"1979","unstructured":"Levy RC, Smith JB, Silver MT, Saia J, Walnski P, Weiner L. Detection of thromboxane B2 in variant angina. Prostaglandins Med 1979;2:243-9.","journal-title":"Prostaglandins Med"},{"issue":"34","key":"ref_24","first-page":"204","article-title":"The standardised normal Ivy bleeding time and it's prolongation by aspirin","volume":"1969","author":"CH, Jr, Mielke; MM, Kaneshiro; IA, Maher","unstructured":"Mielke CH Jr, Kaneshiro MM, Maher IA. The standardised normal Ivy bleeding time and it's prolongation by aspirin. Blood 1969;34:204-10.","journal-title":"Blood"},{"key":"ref_25","article-title":"Interaction of lipoprotein lipase with native and modified heparin-like polysacchardies","author":"Bengtsson, G.; Olivecroma, T.; Hook, M.; Riesenfeld, J.; Linahl, U.","unstructured":"Bengtsson G, Olivecroma T, Hook M, Riesenfeld J, Linahl U. Interaction of lipoprotein lipase with native and modified heparin-like polysacchardies. Biochem J (in press).","journal-title":"Biochem J"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0014-4827(73)90388-1","article-title":"Sulphated mucopolysaccharide synthesis and secretion in endothelial cell culture","volume":"76","author":"Buonassisi, V.","year":"1973","unstructured":"Buonassisi V. Sulphated mucopolysaccharide synthesis and secretion in endothelial cell culture. Exp Cell Res 1973;76:363-78.","journal-title":"Exp Cell Res"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/0049-3848(80)90208-X","article-title":"Anticoagulant activities and effects on platelets of a heparin fragment with high affinity for antithrombin","volume":"18","author":"Holmer, E.; Lindahl, U.; Backstrom, G.","year":"1980","unstructured":"Holmer E, Lindahl U, Backstrom G, et al. Anticoagulant activities and effects on platelets of a heparin fragment with high affinity for antithrombin. Thromb Res 1980;18:861-9.","journal-title":"Thromb Res"},{"key":"ref_28","first-page":"395","volume":"193","author":"Biochemy","year":"1981","unstructured":"Biochemy 1981;193:395-400."},{"key":"ref_29","article-title":"Accepted 21","year":"1981","unstructured":"(Accepted 21 October 1981)"},{"key":"ref_30","article-title":"They are used in such diseases where there is no manifest distemper of the first qualities, viz heat and cold, for example; In obstruction of the bowels, where cold medicines might make the obstruction greater, and hot medicines cause a fever. In fevers of flegm, where the cause is cold and moist, and the effect hot and dry; in such, use temperate medicines which may neither encrease the fever by their heat, nor condensate the flegm by their coldness. Besides, because contraries are taken away by their contraries, and every like maintained by its like, they are of great use, to preserve the constitution of the body temperate, and the body itself in strength and vigour, and may be used without danger, or fear of danger, by considering which part of the body is weak, and using such temperate medicines as are appropriated to that part","volume-title":"The Complete Herbal","year":"1616","unstructured":"They are used in such diseases where there is no manifest distemper of the first qualities, viz heat and cold, for example; In obstruction of the bowels, where cold medicines might make the obstruction greater, and hot medicines cause a fever. In fevers of flegm, where the cause is cold and moist, and the effect hot and dry; in such, use temperate medicines which may neither encrease the fever by their heat, nor condensate the flegm by their coldness. Besides, because contraries are taken away by their contraries, and every like maintained by its like, they are of great use, to preserve the constitution of the body temperate, and the body itself in strength and vigour, and may be used without danger, or fear of danger, by considering which part of the body is weak, and using such temperate medicines as are appropriated to that part. (Nicholas Culpeper (1616-54) The Complete Herbal, 1850.)"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.284.6313.375","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,3]],"date-time":"2021-10-03T22:30:54Z","timestamp":1633300254000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.284.6313.375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1982,2,6]]},"references-count":30,"journal-issue":{"issue":"6313","published-print":{"date-parts":[[1982,2,6]]}},"URL":"https:\/\/doi.org\/10.1136\/bmj.284.6313.375","relation":{},"ISSN":["0959-8138","1468-5833"],"issn-type":[{"value":"0959-8138","type":"print"},{"value":"1468-5833","type":"electronic"}],"subject":[],"published":{"date-parts":[[1982,2,6]]}}}